Idorsia
Ivan Schindelholz is a Principal Scientific Associate in Process Research at Idorsia Pharmaceuticals Ltd, where responsibilities include deputizing for the line manager and maintaining oversight of emerging technologies in process chemistry. Previously, Ivan held the position of Senior Research Associate at Actelion, focusing on the implementation and development of new technologies and the interpretation of advanced process safety data. Ivan’s career began at the University of Fribourg, where coordination of the "Synthesis Lab" unit supported academic research. Academically, Ivan holds an Ing.-Dipl. HES in Chemistry from the College of Engineering and Architecture of Fribourg, alongside a Federal Diploma of Vocational Education and Training in Biology.
This person is not in any teams
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.